Clinical Trial: Registry of Relatives and Patients Carrying Pathogenic Germline DDX41 Variants and Emerging New Syndromes

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07925697) titled 'Registry of Relatives and Patients Carrying Pathogenic Germline DDX41 Variants and Emerging New Syndromes' on Nov. 04.

Brief Summary: The preDDX registry aims to study germline genetic predispositions to myeloid neoplasms, in particular those associated with pathogenic DDX41 variants and emerging syndromes.

Study Start Date: Nov. 15

Study Type: OBSERVATIONAL

Condition: Myeloid Neoplasms (AML/MDS)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Groupe Francophone des Myelodysplasies

Published by HT Digital Content Services with permission from Health Daily Digest....